US20060257435A1 - Concentrated water-dispersible vitamin compositions - Google Patents

Concentrated water-dispersible vitamin compositions Download PDF

Info

Publication number
US20060257435A1
US20060257435A1 US11/490,897 US49089706A US2006257435A1 US 20060257435 A1 US20060257435 A1 US 20060257435A1 US 49089706 A US49089706 A US 49089706A US 2006257435 A1 US2006257435 A1 US 2006257435A1
Authority
US
United States
Prior art keywords
vitamin
composition
water
precursor
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/490,897
Inventor
Michel Crepeau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adisseo France SAS
Original Assignee
Adisseo France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adisseo France SAS filed Critical Adisseo France SAS
Priority to US11/490,897 priority Critical patent/US20060257435A1/en
Publication of US20060257435A1 publication Critical patent/US20060257435A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates to new water-dispersible compositions to provide one or more of vitamins E, A and D 3 to an animal.
  • the present invention provides a water-dispersible liquid vitamin composition comprising:
  • a vitamin component selected from the group consisting of:
  • composition is substantially free of water.
  • Component a) of the composition may be from 45% to 85% by weight.
  • the liquid vitamin composition consists essentially of the ingredients listed in the foregoing description of the composition.
  • the vitamins are suitably provided as the oily derivative of the vitamin, such as the lower alkyl esters of the vitamin as a solution or suspension in an oil (e.g., a veterinarily acceptable oil).
  • lower alkyl is generally meant C1-C6 alkyl which is optionally substituted by one or more halogens.
  • Vitamin A may be provided as retinyl propionate.
  • Vitamin E may be provided as, e.g, (DL) alpha tocopheryl acetate.
  • Suppliers of the vitamins or precursors thereof include Hoffman LaRoche Corporation, and Aventis Animal Nutrition. Such products are generally known to those skilled in the art.
  • the oil is, e.g., a fatty acid oil, such as a vegetable oil, as needed to provide-the compositions.
  • oils are acceptable as food additives and known to the person skilled in the art.
  • oils include soybean oil, corn oil, canola oil, peanut oil and the like.
  • the oil may be composed of or include a manufacturing by-product.
  • the composition may further comprise from 0 to 5% of a stabilizer.
  • the stabilizer enhances vitamin stability and keeps the composition as a flowable liquid for an extended period of time, generally from 1 to 6 months.
  • the stabilizer may also function as an anti-gelling agent and/or as an antifreeze.
  • Suitable stabilizers include propylene glycol, sorbitol and glycerine.
  • the preferred agent is propylene glycol.
  • the ratio of the alkyl lactate to the alcohol is from 1:1 to 3:1, preferably from 1.5:1 to 2.8:1.
  • mono-hydroxy alcohols examples include ethanol, n-propanol or isopropanol.
  • the mono-hydroxy alcohol is preferably a normal alcohol. Propanol is highly preferred.
  • the amount of mono-hydroxy alcohol may be from about 2% to 5%, or from about 3% to 5%.
  • Alkyl lactates that may be used according to the invention include methyl lactate, ethyl lactate, n-propyl lactate, iso-propyl lactate, n-butyl lactate, iso-butyl lactate, sec-butyl lactate, tert-butyl lactate, n-pentyl lactate, n-hexyl lactate and other isomeric forms thereof.
  • the alcohol portion of the ester may be optionally substituted by one or more halogens.
  • Ethyl lactate and butyl lactate are examples of preferred alkyl lactates that are used in the invention. All enantiomeric and diasteromeric forms of lactate esters are embraced by the present invention. Lactate esters of L(+) lactic acid are generally preferred.
  • substantially free of water may be meant less than 1%, or less than 0.5% or less than 0.1% by weight water in the composition.
  • the emulsifiers according to the present invention may be of any type of emulsifiers, and are preferably non-ionic surfactants.
  • non-ionic surfactants include polyethylene glycol esters and ethoxylated sorbitan fatty acid esters.
  • these groups of surfactants include Polysorbate 80, Polysorbate 80K, PEG 400, Alkamuls® PSMO-20, Alkamuls® 400-MO, T-MAZ 80K, MAPEG® 400 Mo and the like and are generally known to those skilled in the art.
  • compositions of the present invention may have viscosities that are from 1000 cP to 10000 cP at 0° C. and from 50 cP to 2000 cP at 10° C. It is understood that viscosities are measured by the Brookfield method known to those of skill in the art and specifically described in example 7 of this application.
  • the composition may be quickly dispersed in water. That is the composition adequately disperses into water within 2 minutes, preferably within 20 seconds, when added at a ratio of composition to water of from 1 g/kg to 100 g/kg, preferably from 3 to 10 g/kg.
  • a ratio of composition to water of from 1 g/kg to 100 g/kg, preferably from 3 to 10 g/kg.
  • the composition may also comprise a fungicide.
  • a fungicide Any suitable fungicide acceptable in veterinary medicine may be used and in particular potassium sorbate is preferred. When a fungicide is used, it is present in the composition in trace amounts, for example, from about 0.05% to 0.3% by weight of the composition.
  • each vitamin in the compositions may be varied to satisfy the specific requirements of the product desired.
  • Vitamin A is present in an amount of from 800,000 to 1,200,000 IU/g, preferably from 800,000 to 1,000,000 IU/g.
  • Vitamin D3 is generally present in an amount of from 50,000 to 1,200,000 IU/g, preferably from 100,000 to 1,000,000 IU/g.
  • Vitamin E is generally present in an amount of from 100 to 1000 IU/g, preferably from 200 to 750 IU/g.
  • the Vitamin D3 concentrate used in Table 1 is an oily concentrate prepared from Vitamin D3 resin and contains about 10% by weight Vitamin D3 in vegetable oil.
  • the Vitamin D3/vegetable oil concentrate is stabilized with BHA or BHT and has about 4,000,000 IU/g of Vitamin D3 (pure cholecalciferol, also known as Vitamin D3, has a theoretical potency of 40,000,000 IU/g).
  • the Vitamin E precursor used in Table 1 is 94.5% by weight pure dl-alpha tocopheryl acetate in oil (945 IU/g).
  • Vitamin Vitamin or Product Name Vitamin Precursor Potency (IU/g) precursor % weight oil A1000 A Retinyl propionate 1,000,000 38.7 10.3 AD3 1000/200 A Retinyl propionate 1,000,000 38.7 10.3 D3 None 200,000 0.52 4.68 AD3 1000/100 A Retinyl propionate 1,000,000 38.7 10.3 D3 None 100,000 2.34 0.26 AD3E 800/200/200 A Retinyl propionate 800,000 31.0 8.2 D3 None 200,000 0.52 4.68 E dl alpha tocopheryl 200 20.6 1.2 acetate E60 E dl alpha tocopheryl 600 61.8 3.6 acetate E75 E dl alpha tocopheryl 750 77.3 4.5 acetate E80 E dl alpha tocopheryl 800 82.4 4.8 acetate
  • a composition containing the ingredients in Table 2 was prepared by sequentially adding, under agitation, 94.5% by weight pure dl-alpha tocopheryl acetate in oil, emulsifier (PEG 400), ethyl lactate and propanol and mixing until homogeneous (generally two hours).
  • PEG 400 emulsifier
  • PEG 400 emulsifier
  • ethyl lactate ethyl lactate
  • propanol emulsifier
  • a composition containing the ingredients in Table 6 was prepared by the procedure of Example 1 where products are added sequentially under agitation and mixed until homogeneous TABLE 6 Ingredient Kilograms PerCent Vitamin D3 52.5 5.25 Retinyl Propionate 489.5 48.95 Polysorbate 80 70.0 7.00 PEG 400 MO 276.0 27.60 Ethoxyquin 30.0 3.00 Ethyl Lactate 50.0 5.00 Propanol 32.0 3.20 Total 1000.0 100
  • the viscosity of the composition was 800 cP at 0° C. and 350 cP at 10° C. The composition adequately dispersed into water at 100 g/kg water at 20 degrees C.
  • composition is added to 50 ml of water (room temperature which is from about 15° C. to about 25° C.) in a 100 ml flat-bottomed beaker and stirred with rod manually for 20 seconds.
  • the resulting emulsion is examined and rated according to the following scale. 1. No emulsion or dispersion; composition is separated from water 2. Partial emulsion/dispersion but large agglomerations of test product are observed 3. Almost complete emulsion/dispersion; small agglomerations are visible 4. Complete emulsion/dispersion; homogeneous liquid without any visible agglomerations
  • compositions of Examples 1, 2, 3, 4 and 5 adequately dispersed into water at 100 g/kg water at 20° C.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A water-dispersible vitamin composition containing Vitamins A, D3 or E, or a precursor thereof, an alkyl lactate and an emulsifier and is substantially free of water.

Description

  • The present invention relates to new water-dispersible compositions to provide one or more of vitamins E, A and D3 to an animal.
  • The present invention provides a water-dispersible liquid vitamin composition comprising:
  • a) from 40% to 90% by weight of a vitamin component selected from the group consisting of:
      • (i) one or more precursors of Vitamin A;
      • (ii) one or more precursors of Vitamin E;
      • (iii) a mixture of one or more precursors of Vitamin A and one or more precursors of Vitamin E;
      • (iv) a mixture of one or more precursors of Vitamin A and Vitamin D3;
      • (v) a mixture of one or more precursors of Vitamin E and Vitamin D3; and
      • (vi) a mixture of one or more precursors of Vitamin A, one or more precursors of Vitamin E, and Vitamin D3;
  • b) from 2% to 10% of a C1 to C6 alkyl lactate;
  • c) from 0% to 10% of a C2 to C6 mono-hydroxy alcohol;
  • d) from 5% to 50% of a one or more veterinarily acceptable emulsifiers; and
  • e) from 1% to 12% of an oil;
  • wherein the composition is substantially free of water.
  • Component a) of the composition may be from 45% to 85% by weight.
  • It should be understood that in the present specification and claims by the term “%” is meant percent by weight unless expressly noted otherwise.
  • In certain embodiments of the present invention, the liquid vitamin composition consists essentially of the ingredients listed in the foregoing description of the composition.
  • The vitamins are suitably provided as the oily derivative of the vitamin, such as the lower alkyl esters of the vitamin as a solution or suspension in an oil (e.g., a veterinarily acceptable oil). By the term lower alkyl is generally meant C1-C6 alkyl which is optionally substituted by one or more halogens. For example Vitamin A may be provided as retinyl propionate. Vitamin E may be provided as, e.g, (DL) alpha tocopheryl acetate. Suppliers of the vitamins or precursors thereof include Hoffman LaRoche Corporation, and Aventis Animal Nutrition. Such products are generally known to those skilled in the art.
  • The oil is, e.g., a fatty acid oil, such as a vegetable oil, as needed to provide-the compositions. Such oils are acceptable as food additives and known to the person skilled in the art. Such oils include soybean oil, corn oil, canola oil, peanut oil and the like. In the case of vitamin E, or its precursor dl-alpha tocopheryl acetate, the oil may be composed of or include a manufacturing by-product.
  • In another aspect of the invention, the composition may further comprise from 0 to 5% of a stabilizer. The stabilizer enhances vitamin stability and keeps the composition as a flowable liquid for an extended period of time, generally from 1 to 6 months. The stabilizer may also function as an anti-gelling agent and/or as an antifreeze. Suitable stabilizers include propylene glycol, sorbitol and glycerine. The preferred agent is propylene glycol.
  • In another aspect of the invention, the ratio of the alkyl lactate to the alcohol is from 1:1 to 3:1, preferably from 1.5:1 to 2.8:1.
  • Examples of mono-hydroxy alcohols include ethanol, n-propanol or isopropanol. The mono-hydroxy alcohol is preferably a normal alcohol. Propanol is highly preferred. In one embodiment of the present invention, the amount of mono-hydroxy alcohol may be from about 2% to 5%, or from about 3% to 5%.
  • Alkyl lactates that may be used according to the invention include methyl lactate, ethyl lactate, n-propyl lactate, iso-propyl lactate, n-butyl lactate, iso-butyl lactate, sec-butyl lactate, tert-butyl lactate, n-pentyl lactate, n-hexyl lactate and other isomeric forms thereof. The alcohol portion of the ester may be optionally substituted by one or more halogens. Ethyl lactate and butyl lactate are examples of preferred alkyl lactates that are used in the invention. All enantiomeric and diasteromeric forms of lactate esters are embraced by the present invention. Lactate esters of L(+) lactic acid are generally preferred.
  • By the term substantially free of water may be meant less than 1%, or less than 0.5% or less than 0.1% by weight water in the composition.
  • The emulsifiers according to the present invention may be of any type of emulsifiers, and are preferably non-ionic surfactants. Examples of non-ionic surfactants include polyethylene glycol esters and ethoxylated sorbitan fatty acid esters. Examples of these groups of surfactants include Polysorbate 80, Polysorbate 80K, PEG 400, Alkamuls® PSMO-20, Alkamuls® 400-MO, T-MAZ 80K, MAPEG® 400 Mo and the like and are generally known to those skilled in the art.
  • The compositions of the present invention may have viscosities that are from 1000 cP to 10000 cP at 0° C. and from 50 cP to 2000 cP at 10° C. It is understood that viscosities are measured by the Brookfield method known to those of skill in the art and specifically described in example 7 of this application.
  • Another aspect of the present invention is that the composition may be quickly dispersed in water. That is the composition adequately disperses into water within 2 minutes, preferably within 20 seconds, when added at a ratio of composition to water of from 1 g/kg to 100 g/kg, preferably from 3 to 10 g/kg. By the term “adequately disperses” is meant that the composition disperses into water and forms a finely dispersed emulsion (e.g., under the conditions specified in Example 6).
  • The composition may also comprise a fungicide. Any suitable fungicide acceptable in veterinary medicine may be used and in particular potassium sorbate is preferred. When a fungicide is used, it is present in the composition in trace amounts, for example, from about 0.05% to 0.3% by weight of the composition.
  • The concentration of each vitamin in the compositions may be varied to satisfy the specific requirements of the product desired. Generally, Vitamin A is present in an amount of from 800,000 to 1,200,000 IU/g, preferably from 800,000 to 1,000,000 IU/g. Vitamin D3 is generally present in an amount of from 50,000 to 1,200,000 IU/g, preferably from 100,000 to 1,000,000 IU/g. Vitamin E is generally present in an amount of from 100 to 1000 IU/g, preferably from 200 to 750 IU/g.
  • The specific products set forth in Table 1 are contemplated by the invention. Stock solutions or suspensions of vitamins and vitamin precursors are generally supplied at specific International potency units per/gram (IU/g). For example, the precursor to Vitamin A used in the formulations of Table 1 is retinyl propionate which is used as a 79% by weight solution of retinyl propionate dissolved in canola oil and stabilized with 1% by weight ethoxyquin. This means that the retinyl propionate/canola oil solution contains s about 2,200,000 IU/g of Vitamin A (pure all trans retinyl propionate has a theoretical potency of 2,780,000 IU/g). The Vitamin D3 concentrate used in Table 1 is an oily concentrate prepared from Vitamin D3 resin and contains about 10% by weight Vitamin D3 in vegetable oil. The Vitamin D3/vegetable oil concentrate is stabilized with BHA or BHT and has about 4,000,000 IU/g of Vitamin D3 (pure cholecalciferol, also known as Vitamin D3, has a theoretical potency of 40,000,000 IU/g). The Vitamin E precursor used in Table 1 is 94.5% by weight pure dl-alpha tocopheryl acetate in oil (945 IU/g).
    TABLE 1
    % weight of
    Vitamin Vitamin or
    Product Name Vitamin Precursor Potency (IU/g) precursor % weight oil
    A1000 A Retinyl propionate 1,000,000 38.7 10.3
    AD3 1000/200 A Retinyl propionate 1,000,000 38.7 10.3
    D3 None 200,000 0.52 4.68
    AD3 1000/100 A Retinyl propionate 1,000,000 38.7 10.3
    D3 None 100,000 2.34 0.26
    AD3E 800/200/200 A Retinyl propionate 800,000 31.0 8.2
    D3 None 200,000 0.52 4.68
    E dl alpha tocopheryl 200 20.6 1.2
    acetate
    E60 E dl alpha tocopheryl 600 61.8 3.6
    acetate
    E75 E dl alpha tocopheryl 750 77.3 4.5
    acetate
    E80 E dl alpha tocopheryl 800 82.4 4.8
    acetate
    • EXAMPLE 1
  • A composition containing the ingredients in Table 2 was prepared by sequentially adding, under agitation, 94.5% by weight pure dl-alpha tocopheryl acetate in oil, emulsifier (PEG 400), ethyl lactate and propanol and mixing until homogeneous (generally two hours).
    TABLE 2
    Ingredient Kilograms PerCent
    94.5% pure dl-alpha tocopheryl 817.5 81.75
    acetate (in oil)
    PEG 400 82.5 8.25
    Ethyl Lactate 70 7.0
    Propanol 30 3.0
    Total 1000 100
    • EXAMPLE 2
  • A composition containing the ingredients in Table 3 was prepared by the procedure of Example 1 where products were added sequentially under agitation and mixed until homogeneous.
    TABLE 3
    Ingredient Kilograms PerCent
    Retinyl Propionate 79% in canola oil 489.5 48.95
    Polysorbate 80 61.0 6.10
    PEG 400 MO 339.5 33.95
    Ethoxyquin 30.0 3.00
    Ethyl Lactate 50.0 5.00
    Propanol 30.0 3.00
    Total 1000.0 100
    • EXAMPLE 3
  • A composition containing the ingredients in Table 4 was. prepared by the procedure of Example 1 where products were added sequentially under agitation and mixed until homogeneous.
    TABLE 4
    Ingredient Kilograms PerCent
    Retinyl Propionate 79% in canola oil 489.5 48.95
    Vitamin D3 10% in oil 26.3 2.63
    Polysorbate 80 30.0 3.00
    PEG 400 MO 274.2 27.42
    Ethyl Lactate 50.0 5.00
    BHT 30.0 3.00
    Propanol 100.0 10.00
    Total 1000.0 100
    • EXAMPLE 4
  • A composition containing the ingredients in Table 5 was prepared by the procedure of Example 1 where products were added sequentially under agitation and mixed until homogeneous.
    TABLE 5
    Ingredient Kilograms PerCent
    Vitamin D3 10% in oil 52.5 5.25
    94.5% pure dl-alpha tocopheryl 218.0 21.8
    acetate (in oil)
    Retinyl Propionate 79% in canola oil 391.6 39.16
    Polysorbate 80 37.9 3.79
    PEG 400 MO 188.0 18.80
    Ethoxyquin 30.0 3.00
    Ethyl Lactate 50.0 5.00
    Propanol 32.0 3.20
    Total 1000.0 100

    The viscosity of the composition was 1300 cP at 0° C. and 500 cP at 100° C. The composition adequately dispersed into water at 100 g/kg water at 20 degrees C.
    • EXAMPLE 5
  • A composition containing the ingredients in Table 6 was prepared by the procedure of Example 1 where products are added sequentially under agitation and mixed until homogeneous
    TABLE 6
    Ingredient Kilograms PerCent
    Vitamin D3 52.5 5.25
    Retinyl Propionate 489.5 48.95
    Polysorbate 80 70.0 7.00
    PEG 400 MO 276.0 27.60
    Ethoxyquin 30.0 3.00
    Ethyl Lactate 50.0 5.00
    Propanol 32.0 3.20
    Total 1000.0 100

    The viscosity of the composition was 800 cP at 0° C. and 350 cP at 10° C. The composition adequately dispersed into water at 100 g/kg water at 20 degrees C.
    • EXAMPLE 6
  • About 5 drops (approx 0.15 g) of composition is added to 50 ml of water (room temperature which is from about 15° C. to about 25° C.) in a 100 ml flat-bottomed beaker and stirred with rod manually for 20 seconds. The resulting emulsion is examined and rated according to the following scale.
    1. No emulsion or dispersion; composition is separated from water
    2. Partial emulsion/dispersion but large agglomerations of test
    product are observed
    3. Almost complete emulsion/dispersion; small
    agglomerations are visible
    4. Complete emulsion/dispersion; homogeneous liquid without
    any visible agglomerations
  • The compositions of Examples 1, 2, 3, 4 and 5 adequately dispersed into water at 100 g/kg water at 20° C.
    • EXAMPLE 7
  • Viscosity is measured with a Brookfield DV-II+Viscometer (Brookfield Engineering Labs, Middleboro, Mass.) using RV spindle #3. The composition to be tested was placed in a 200 ml flat-bottomed sample jar and chilled at −20° C. for several hours. The viscometer functions in combination with a microcomputer supplied by Brookfield and uses a timed-stop program whereby a viscosity reading was taken every 30 seconds. Viscosity, torque and temperature are measured until the sample warmed to about from 10° C. to 15° C.
  • The following viscosities were recorded:
    Example Temp. A Viscosity A Temp B Viscosity B
    1 0° C. 6000 cP  10° C. 1200 cP 
    2 0° C. 800 cP 10° C. 400 cP
    3 0° C. 250 cP 10° C. 200 cP
    4 0° C. 1300 cP  10° C. 500 cP
    5 0° C. 800 cP 10° C. 350 cP

    It should be understood that the preceeding is merely a detailed description of the embodiments of the invention and that numerous changes to the disclosed embodiments can be made in accordance with the disclosure herein without departing from the spirit or scope of the invention. The preceding description, therefore, is not meant to limit the scope of the invention. Rather, the scope of the invention is to be determined only by the appended claims and their equivalents.

Claims (14)

1. A water-dispersible liquid vitamin composition comprising:
a) from 40% to 90% by weight of the composition of a vitamin component dissolved in from 1% to 12% by weight of the composition of an oil the vitamin component being selected from the group consisting of:
(i) one or more precursors of Vitamin A;
(ii) one or more precursors of Vitamin E;
(iii) a mixture of one or more precursors of Vitamin A and one or more precursors of Vitamin E;
(iv) a mixture of one or more precursors of Vitamin A and Vitamin D3;
(v) a mixture of one or more precursors of Vitamin E and Vitamin D3; and
(vi) a mire of one or more precursors of Vitamin A, one or more precursors of Vitamin E, and Vitamin D3,
b) from 2% to 10% of a C1 to C6 alkyl lactate;
c) from 0% to 10% of a C2 to C6 mono-hydroxy alcohol;
d) from 5% to 50% of a one or more veterinarily acceptable emulsifiers; and
wherein the composition is substantially free of water.
2. The composition of claim 1, wherein said composition further comprises from 0% to 5% of a stabilizer.
3. The composition of claim 1, wherein said composition comprises said alkyl lactate and said mono-hydroxy alcohol and the ratio of the alkyl lactate to the mono-hydroxy alcohol is from 1:1 to 3:1.
4. The composition of claim 3, wherein the ratio of b) to c) is from 1.5:1 to 2.8:1.
5. The composition of claim 1, wherein the C2-C6 mono-hydroxy alcohol is present in an amount from 2% to 5%.
6. The composition of claim 1, wherein the emulsifier is a non-ionic surfactant.
7. The composition of claim 1, wherein the viscosity of the composition is from 1000 cP to 10000 cP at 0 degrees C.
8. The composition of claim 1, wherein said composition adequately disperses into water within 2 minutes when added at a ratio of composition to water of from 1 g/kg to 100 g/kg.
9. The composition of claim 1, wherein said composition adequately disperses into water within 20 seconds when added at a ratio of composition to water of from 1 g/kg to 100 g/kg.
10. The composition of claim 1, wherein the C1 to C6 alkyl lactate is ethyl lactate.
11. The composition of claim 1, wherein the C2 to C6 mono-hydroxy alcohol is propanol.
12. A food additive comprising the composition of claim 1.
13. A water-dispersible liquid vitamin composition comprising.
a) from 40% to 90% by weight of the composition of a vitamin component dissolved in from 1% to 12% by weight of the composition of an oil, the vitamin component being selected from the group consisting of.
(i) a precursor of vitamin A;
(ii) a precursor of vitamin E;
(iii) a mixture of a precursor of vitamin A and a precursor of vitamin E;
(iv) a mixture of a precursor of vitamin A and a precursor of vitamin D3;
(v) a mixture of a precursor of vitamin E and a precursor of vitamin D3;
(vi) a mixture of a precursor of vitamin A, a precursor of vitamin E and a precursor of vitamin D3;
b) from 2% to 10% of C1 to C6 alkyl lactate;
c) from 0% to 10% of a C2 to C6 mono-hydroxy alcohol;
d) from 5% to 50% of one or more veterinarily acceptable emulsifiers;
wherein the composition is substantially free of water.
14. A water-dispersible liquid vitamin composition comprising.
a) from 40% to 90% by weight of the composition of a vitamin component dissolved in from 1% to 12% by weight of the composition of an oil, the vitamin component being selected from the group consisting of:
(i) retinyl propionate;
(ii) dl alpha tocopheryl acetate;
(iii) a mixture of retinyl propionate and dl alpha tocopheryl acetate;
(iv) a mixture of retinyl propionate and vitamin D3;
(v) a mixture of dl alpha tocopheryl acetate and vitamin D3; and
(vi) a mixture of retinyl propionate, dl alpha tocopheryl acetate and Vitamin D3;
b) from 2% to 10% of C1 to C6 alkyl lactate;
c) from 0% to 10% of a C2 to C6 mono-hydroxy alcohol;
d) from 5% to 50% of one or more veterinarily acceptable emulsifiers;
wherein the composition is substantially free of water.
US11/490,897 2001-08-03 2006-07-21 Concentrated water-dispersible vitamin compositions Abandoned US20060257435A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/490,897 US20060257435A1 (en) 2001-08-03 2006-07-21 Concentrated water-dispersible vitamin compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/920,365 US7081248B2 (en) 2001-08-03 2001-08-03 Concentrated water-dispersible vitamin compositions
US11/490,897 US20060257435A1 (en) 2001-08-03 2006-07-21 Concentrated water-dispersible vitamin compositions

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/920,365 Continuation US7081248B2 (en) 2001-08-03 2001-08-03 Concentrated water-dispersible vitamin compositions

Publications (1)

Publication Number Publication Date
US20060257435A1 true US20060257435A1 (en) 2006-11-16

Family

ID=25443610

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/920,365 Expired - Fee Related US7081248B2 (en) 2001-08-03 2001-08-03 Concentrated water-dispersible vitamin compositions
US11/490,897 Abandoned US20060257435A1 (en) 2001-08-03 2006-07-21 Concentrated water-dispersible vitamin compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/920,365 Expired - Fee Related US7081248B2 (en) 2001-08-03 2001-08-03 Concentrated water-dispersible vitamin compositions

Country Status (2)

Country Link
US (2) US7081248B2 (en)
CA (1) CA2393357A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2558202A1 (en) * 2006-09-14 2006-11-23 Reinhold W. Vieth Vitamin d compositions and method of administration to infants
FR2910323A1 (en) * 2006-12-26 2008-06-27 Virbac Sa Sa Liquid anhydrous composition, useful e.g. to prepare oral medications that are diluted with drinking water to prevent/treat diseases of livestock, comprises active ingredient dissolved in organic solvents, surfactant and xanthan gum

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932634A (en) * 1973-06-28 1976-01-13 Pfizer Inc. High potency vitamin water dispersible formulations
US4075333A (en) * 1975-02-14 1978-02-21 Hoffmann-La Roche, Inc. Stable injectable vitamin compositions
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US6162419A (en) * 1996-11-26 2000-12-19 Nicholas V. Perricone Stabilized ascorbyl compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932634A (en) * 1973-06-28 1976-01-13 Pfizer Inc. High potency vitamin water dispersible formulations
US4075333A (en) * 1975-02-14 1978-02-21 Hoffmann-La Roche, Inc. Stable injectable vitamin compositions
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US6162419A (en) * 1996-11-26 2000-12-19 Nicholas V. Perricone Stabilized ascorbyl compositions

Also Published As

Publication number Publication date
CA2393357A1 (en) 2003-02-03
US20030078243A1 (en) 2003-04-24
US7081248B2 (en) 2006-07-25

Similar Documents

Publication Publication Date Title
US7632518B2 (en) 25-hydroxy vitamin D3 compositions
CA2079325C (en) Nutritional supplement containing vitamin e
US5234695A (en) Water dispersible vitamin E composition
EP0551638B1 (en) Stable fluid preparation of fat-soluble substances
US3895117A (en) Animal feed supplement and method for its preparation
AU2018208993B2 (en) Stable and liposoluble active ingredient composition, microcapsule, and preparation method and application thereof
US20060257435A1 (en) Concentrated water-dispersible vitamin compositions
US11013807B2 (en) Stable fat-soluble active ingredient composition, microcapsule and process of preparation and use thereof
AU2014243047B2 (en) Lutein composition suitable for infant food formulations
US3253992A (en) Water dispersible, anhydrous, water insoluble vitamin preparation and aqueous dispersions thereof
EP0880403B1 (en) Stable, low-viscosity feedstuff dispersion of molasses and a fat or an oil or an acid from fat or oil or a mixture thereof
US6852332B2 (en) Liquid vitamin composition
US20030092688A1 (en) Non-combustible water-dispersible vitamin compositions
US3708583A (en) Stabilized vitamin a additive
US4022913A (en) High potency vitamin A compositions
CN103181458A (en) Grease emulsifying agent for coated feed and preparation process thereof
JP5619335B2 (en) Hand cream manufacturing method
US6329423B1 (en) Stable liquid formulations of high vitamin E content
JP2546269B2 (en) Tocopheroic acid emulsion
EP0821950A2 (en) Clear hydroalcoholic solution of multivitamins containing physiologically active quantity of beta-carotene
JPS6160619A (en) Dispersible powder
US3359167A (en) Vitamin a compositions
EP3487319A1 (en) Propyl gallate-containing vitamin preparations
EP2917177A1 (en) Beta carotene preparation
DE1467929B (en) Emulsifiable, non-aqueous solution of olive vitamins

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION